Meet InGel Therapeutics | 2023 Harvard President's Innovation Challenge
发布时间 2023-05-24 16:00:22 来源
摘要
InGel Therapeutics, the $75,000 winner in the Alumni & Affiliates Health & Life Sciences Track, is a regenerative cell-therapy biotech leveraging novel neuro-protective and neuro-repairing mechanisms to tackle retinal degeneration.
Learn more about InGel Therapeutics: https://pic2023.innovationlabs.harvard.edu/team/ingel-therapeutics
The yearly President’s Innovation Challenge is an invitation to Harvard students and select alumni & affiliate-led ventures to propel their ideas forward. The PIC is also an opportunity to win a share of $515,000 in non-dilutive funding, made possible by a gift from the Bertarelli Foundation. Throughout the seven-month process, teams develop their ventures with robust support from the Harvard Innovation Labs.
https://innovationlabs.harvard.edu/
GPT-4正在为你翻译摘要中......
